Merck Serono strengthens executive team; ProStrakan names new CEO; Sanofi Pasteur MSD gets new president

8 July 2011

German drug major Merck KGaA (MRK: DE) says it is strengthening its executive management team with two appointments at its Switzerland-based Merck Serono subsidiary. Belen Garijo has been appointed chief operating officer, effective September 1, 2011, and Annalisa Jenkins has been named global head of Drug Development & Medical, effective September 5.

In their newly-created positions, both Drs Garijo and Jenkins will be based in Geneva and report directly to Stefan Oschmann, a member of Merck’s executive board and head of Merck Serono.

Dr Garijo joins Merck Serono from Sanofi, where she was senior vice president, Global Operations Region Europe. Dr Jenkins joins from Bristol-Myers Squibb, where she was senior vice president, Global Medical.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK